000 01166 a2200337 4500
005 20250513040308.0
264 0 _c19930621
008 199306s 0 0 eng d
022 _a0008-5472
040 _aNLM
_beng
_cNLM
100 1 _aBerg, S L
245 0 0 _aPharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.
_h[electronic resource]
260 _bCancer research
_cJun 1993
300 _a2587-90 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
650 0 4 _aAdult
650 0 4 _aAnthraquinones
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aGranulocyte Colony-Stimulating Factor
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPyrazoles
_xadministration & dosage
700 1 _aSavarese, D M
700 1 _aBalis, F M
700 1 _aDenicoff, A M
700 1 _aHillig, M
700 1 _aO'Shaughnessy, J A
700 1 _aPoplack, D G
700 1 _aCowan, K H
773 0 _tCancer research
_gvol. 53
_gno. 11
_gp. 2587-90
999 _c7683746
_d7683746